Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from Syncona Shs GBP ( (GB:SYNC) ).
On January 24, 2025, Syncona Limited announced the purchase of 150,000 of its ordinary shares at a price of 97.3083 GBp each as part of its ongoing share buyback program. This transaction, executed through Deutsche Numis, reflects Syncona’s strategic financial management approach to optimize shareholder value. Following this buyback, the company holds 49,016,793 shares in treasury, adjusting the total voting rights to 623,197,839. The buyback underscores the company’s commitment to leveraging its financial strategy to support its long-term goals in the life science investment sector.
More about Syncona Shs GBP
Syncona Limited is a prominent life science investor dedicated to creating, building, and scaling a portfolio of global leaders in the life science sector. The company focuses on developing transformational treatments for patients with high unmet needs by partnering with world-class academic founders and experienced management teams. Syncona aims to maintain a diversified portfolio of 20-25 leading life science businesses across various development stages, modalities, and therapeutic areas, with a long-term strategy to enhance human life and deliver robust returns to shareholders.
YTD Price Performance: -6.44%
Average Trading Volume: 707,231
Technical Sentiment Consensus Rating: Buy
See more insights into SYNC stock on TipRanks’ Stock Analysis page.
